GeneNews is addressing the major issue in early cancer screening – patient reluctance with inconvenient and intrusive screening methods – with a suite of differentiated molecular diagnostic tests that rely on a convenient in-office blood draw to find cancers of the colon, lung, breast and prostate, early.

GeneNews is dedicated to providing innovative solutions for early cancer detection.  Their mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health outcomes through the early diagnosis of disease. They also work with large healthcare systems to develop and implement processes that lead to higher screening rates and improved metrics around performance and care.​


VISIT WEBSITE Back to Portfolio

Recent News